Please use this identifier to cite or link to this item:
http://acervodigital.unesp.br/handle/11449/65891Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Barretti, Pasqual | - |
| dc.contributor.author | Soares, Vitor | - |
| dc.date.accessioned | 2014-05-27T11:19:47Z | - |
| dc.date.accessioned | 2016-10-25T18:15:55Z | - |
| dc.date.available | 2014-05-27T11:19:47Z | - |
| dc.date.available | 2016-10-25T18:15:55Z | - |
| dc.date.issued | 1999-11-29 | - |
| dc.identifier | http://dx.doi.org/10.3109/08860229909094154 | - |
| dc.identifier.citation | Renal Failure, v. 21, n. 6, p. 603-613, 1999. | - |
| dc.identifier.issn | 0886-022X | - |
| dc.identifier.uri | http://hdl.handle.net/11449/65891 | - |
| dc.identifier.uri | http://acervodigital.unesp.br/handle/11449/65891 | - |
| dc.description.abstract | Three experimental protocols were carried out with the aim of evaluating the role of protein restriction on the progression of the established adriamycin-induced nephropathy, and whether the protective effect of the diet persists after the diet is discontinued. The effect of a low protein diet (LPD) was studied for 6 weeks in protocol 1, 16 weeks in protocol 2 and for 28 weeks in protocol 3. In protocol 3, one group (LL) received LPD and another (NN) was given a normal protein diet (NPD). A third group (LN) received LPD for 16 weeks and then NPD for 12 weeks and a fourth group (NL) was fed NPD for 16 weeks and then LPD for 12 weeks. In protocol I the tubulo- interstitial index (TILl) of rats on LPD (Md = 2, P25 = 0.0; P75 = 3.5) after six weeks, was smaller than that of the animals on NPD (Md = 6.0; P25 = 3.0; P75 = 8.0; p < 0.05). In protocol 2, the group taking LPD presented an area of interstitial fibrosis (IF) (Md= 0.5%, P25 0.2%; P75 = 1.9%) smaller than that of the NPD group (Md = 6.8%; P25 = 5.2%; P75 = 7.1%; P < 0.05). No significant difference in the area of glomerulosclerosis (GSA) was observed between the animals on LPD (Md = 0.0%; P25 = 0.0%, P75 = 0.0%) and NPD (Md = 0.37%; P25 = 02% P75 = 1.25%; p > 0.05). In protocol 3, the group LL showed GSA (Md = 1.3%; P25 0.6%, P75 = 2.5%) and IF (Md = 3.60/0; P25 = 1.6%; P75 = 5.9%) smaller that those of LN (GSA Md = 10.1%; P25 = 6.6%; P75 = 14.8%; IF; Md = 17.3%; P25 = 14.1%; P75 = 24,5%), NL (GSA: Md = 9.1%; P25 = 5,8%; P75 = 11.7%; IF; Md = 25.0%; P25 = 20.4%; P75 = 30%), and NN (GSA: Md = 6. 75%; P25 = 4.9%; P75 = 11.7%; IF: Md = 20.9%; P25 = 16.2%; P75 = 32.4%). In conclusion, in order to be effective, LPD must be introduced early and maintained for a long period of tune. | en |
| dc.format.extent | 603-613 | - |
| dc.language.iso | eng | - |
| dc.source | Scopus | - |
| dc.subject | Adriamycin nephropathy | - |
| dc.subject | Protein restriction | - |
| dc.subject | Proteinuria | - |
| dc.subject | Tubulointterstitial nephritis | - |
| dc.subject | doxorubicin | - |
| dc.subject | animal experiment | - |
| dc.subject | animal model | - |
| dc.subject | controlled study | - |
| dc.subject | creatinine blood level | - |
| dc.subject | diet therapy | - |
| dc.subject | early diagnosis | - |
| dc.subject | interstitial nephritis | - |
| dc.subject | kidney disease | - |
| dc.subject | nephritis | - |
| dc.subject | nonhuman | - |
| dc.subject | priority journal | - |
| dc.subject | protein diet | - |
| dc.subject | protein restriction | - |
| dc.subject | proteinuria | - |
| dc.subject | rat | - |
| dc.subject | Animals | - |
| dc.subject | Antineoplastic Agents | - |
| dc.subject | Diet, Protein-Restricted | - |
| dc.subject | Dietary Proteins | - |
| dc.subject | Doxorubicin | - |
| dc.subject | Kidney | - |
| dc.subject | Male | - |
| dc.subject | Nephritis | - |
| dc.subject | Rats | - |
| dc.subject | Rats, Wistar | - |
| dc.subject | Time Factors | - |
| dc.title | Importance of early and continuous use of protein restriction on the progression of adriamycin nephropathy | en |
| dc.type | outro | - |
| dc.contributor.institution | Universidade Estadual Paulista (UNESP) | - |
| dc.description.affiliation | Department of Internal Medicine Division of Nephrology Botucatu Medical School-UNESP, Botucatu | - |
| dc.description.affiliation | Botucatu Medical School Dept. of Internal Medicine Division of Nephrology, Botucatu, SP 18618-970 | - |
| dc.description.affiliationUnesp | Department of Internal Medicine Division of Nephrology Botucatu Medical School-UNESP, Botucatu | - |
| dc.description.affiliationUnesp | Botucatu Medical School Dept. of Internal Medicine Division of Nephrology, Botucatu, SP 18618-970 | - |
| dc.identifier.doi | 10.3109/08860229909094154 | - |
| dc.identifier.wos | WOS:000083847000003 | - |
| dc.rights.accessRights | Acesso restrito | - |
| dc.relation.ispartof | Renal Failure | - |
| dc.identifier.scopus | 2-s2.0-0032724456 | - |
| Appears in Collections: | Artigos, TCCs, Teses e Dissertações da Unesp | |
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
